Ring Christine bought NRIX
June 25, 2026 · Form 4 insider transaction
Ring Christine bought 13,333 shares of Nurix Therapeutics, Inc. at $7.26 per share, a transaction worth $96.8K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
13,333
Price
$7.26
Total value
$96.8K
InsiderRing Christine
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateJune 25, 2026
Filing dateJune 25, 2026
Shares owned after26,912
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.